INCY 20 Pill: white, capsule/oblong, 16mm
Generic Name: ruxolitinib
The pill with imprint INCY 20 (White, Capsule/Oblong, 16mm) has been identified as Jakafi 20 mg and is used for Polycythemia Vera, Myelofibrosis, Graft Versus Host Disease, and Myeloproliferative Disorders. It belongs to the drug class multikinase inhibitors and is not a controlled substance.
Images for INCY 20
Jakafi
- Generic Name
- ruxolitinib
- Imprint
- INCY 20
- Strength
- 20 mg
- Color
- White
- Size
- 16.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Multikinase inhibitors
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Incyte Corporation
- National Drug Code (NDC)
- 50881-0020
- Inactive Ingredients
-
microcrystalline cellulose,
lactose monohydrate,
silicon dioxide,
hydroxypropyl cellulose (type e),
povidone,
sodium starch glycolate type A potato,
magnesium stearate
Note: Inactive ingredients may vary.
See also:
More about Jakafi (ruxolitinib)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (33)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: multikinase inhibitors
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.